Stepwise Enhancement of HPV16 E6/E7 mRNA Vaccine Efficacy Using HSV-1 gD Epitope Incorporation and Immune-Modulating Agents
This study demonstrates that the therapeutic efficacy of an HPV16 E6/E7 mRNA vaccine against tumors is significantly enhanced by incorporating a ubiquitin tag and a heterologous HSV-1 gD epitope to boost antigen presentation and T-cell help, with further improvements achieved through combination with immunomodulatory agents like entinostat or ADU-S100.